GAVI responds to MSF campaign

in page functions
[French]

In response to statements issued by Medecins Sans Frontieres (MSF), the GAVI Alliance has issued the following statement

  • First, we agree with MSF – we do all want the same things. We want all children everywhere to be protected by immunisation. In fact, GAVI is proud to include MSF as a member of the GAVI Alliance. They are an active member of the steering committee of the GAVI Board’s Civil Society Organisation Constituency.
  • MSF first formally raised the issue of access to the same prices GAVI pays for vaccines at the GAVI Board meeting in December 2012. This issue is currently being discussed through the Alliance’s Governance channels. We find it disappointing that MSF, which knows and is engaged in the GAVI Governance process, has chosen to take on this issue as a public campaign.
  • GAVI works with governments to protect children by providing quality life-saving vaccines at affordable prices to all children in the 73 poorest countries in the world. 65% of the children born today are born in GAVI–supported countries. Non-government organisations, including MSF, play a critical role in the distribution of vaccines in the immunisation programmes of these countries. This work is coordinated in each country by the Ministry of Health, and the large majority of vaccines are funded by GAVI and countries.
  • It’s true that the cost of vaccinating children has increased because the number and effectiveness of vaccines available today is much greater. Immunisation remains one of the most cost effective investments in health.
  • Ten years ago, children were being immunised with just a handful of vaccines based on outdated technology.
  • Over the course of the past 10 years, a large number of new and highly complex vaccines have been produced that protect children against diseases including the two biggest killers – pneumonia and diarrhoea.
  • GAVI has been working hard to bring down the price of these key vaccines. In fact, just last week we announced a 30% reduction in the price of the key Pentavalent vaccine that protects children against five killer diseases.
  • Obtaining such low price agreements with vaccines' manufacturers for the world’s poorest countries is only possible when there are stable forecasts, long-term commitments to large volumes with secure financing agreements from donors and recipient governments working together. Any adjustment to the current way of working will require careful consideration and the support of key constituencies. It is by working together that we can best serve the needs of children and support the long-term development of the countries in which they are born.

close icon

modal window here